TORRENT PHARMACEUTICALS L vs VIJAYA DIAGNOSTIC CEN LTD

A side-by-side comparison of TORRENT PHARMACEUTICALS L (TORNTPHARM) and VIJAYA DIAGNOSTIC CEN LTD (VIJAYA) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.

The verdict

TORRENT PHARMACEUTICALS L and VIJAYA DIAGNOSTIC CEN LTD are evenly matched on the numbers (77). The breakdown below shows where each one wins.

Valuation

How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.

74.52
P/E ratio
79.79
19.76
P/B ratio
14.85
0.78%
Dividend yield
0.15%
₹63.92
EPS
₹16.81

Profitability

How efficiently each company turns capital and sales into profit. Higher is better.

27.40%
Return on equity
19.70%
15.00%
Return on capital
21.00%
33.00%
EBITDA margin
41.00%
15.29%
Net margin
21.25%

Growth

Three-year compounded growth. Faster-growing businesses can justify a higher valuation.

13.27%
Revenue CAGR (3Y)
21.04%
19.75%
Profit CAGR (3Y)
26.73%

Size & financial health

Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.

₹1.61L Cr
Market cap
₹13,777 Cr
₹13,980 Cr
Revenue
₹814 Cr
₹2,138 Cr
Net profit
₹173 Cr
1.79
Debt / equity
0.44
TORRENT PHARMACEUTICALS L
  • + ["Company has a good return on equity (ROE) track record: 3 Years ROE 26.2%", "Company has been maintaining a healthy dividend payout of 57.8%"]
  • ["Stock is trading at 19.8 times its book value", "The company has delivered a poor sales growth of 11.8% over past five years.", "Company might be capitalizing the interest cost"]
VIJAYA DIAGNOSTIC CEN LTD
  • ["Stock is trading at 14.9 times its book value", "Working capital days have increased from -3.87 days to 65.1 days"]
TORRENT PHARMACEUTICALS L full analysis VIJAYA DIAGNOSTIC CEN LTD full analysis

This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.